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Understanding GPCR recognition and folding from
NMR studies of fragments
Jacopo Marino, b Reto Walser,ac Martin Poms ad and Oliver Zerbe *a
Cotranslational protein folding is a vectorial process, and for membrane proteins, N-terminal helical
segments are the ﬁrst that become available for membrane insertion. While structures of many G-
protein coupled receptors (GPCRs) in various states have been determined, the details of their folding
pathways are largely unknown. The seven transmembrane (TM) helices of GPCRs often contain polar
residues within the hydrophobic core, and some of the helices in isolation are predicted to be only
marginally stable in a membrane environment. Here we review our eﬀorts to describe how marginally
hydrophobic TM helices of GPCRs integrate into the membrane in the absence of all compensating
interhelical contacts, ideally capturing early biogenesis events. To this end, we use truncated GPCRs,
here referred to as fragments. We present data from the human Y4 and the yeast Ste2p receptors in
detergent micelles derived from solution NMR techniques. We ﬁnd that the secondary structure in the
fragments is similar to corresponding parts of the entire receptors. However, uncompensated polar or
charged residues destabilize the helices, and prevent proper integration into the lipid bilayer, in
agreement with the biophysical scales from Wimley and White for the partitioning of amino acids into
the membrane-interior. We observe that the stability and integration of single TM helices is improved by
adding neighboring helices. We describe a topology study, in which all possible forms of the Y4 receptor
were made so that the entire receptor is truncated from the N-terminus by one TM helix at a time. We
discover that proteins with an increasing number of helices assume a more deﬁned topology. In
a parallel study, we focused on the role of extracellular loops in ligand recognition. We demonstrate that
transferring all loops of the human Y1 receptor onto the E. coli outer membrane protein OmpA in
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a suitable topology results in a chimeric receptor that displays, albeit reduced, aﬃnity and speciﬁcity for the
cognate ligand. Our data indicate that not all TM helices will spontaneously insert into the helix, and we
suggest that at least for some GPCRs, N-terminal segments might remain associated with the translocon
until their interacting partners are biosynthesized.
Introduction
G-protein coupled receptors (GPCRs) constitute a very impor-
tant class of integral membrane proteins that help transmit
a signal from the outside to the inside of cells. Around 35% of
all commercial drugs are believed to act via binding to GPCRs.1
A network of interactions between the seven transmembrane
(TM) helices, formed by hydrogen bonds, salt-bridges and
hydrophobic contacts confers plasticity upon activation, thus
allowing GPCRs to respond to diﬀerent ligands and bind
diﬀerent intracellular eﬀector proteins.2 The characterization of
subtle structural changes upon GPCR activation is crucial to
developing ligands that activate specic intracellular pathways
exclusively and minimize side eﬀects.3
While the rst low-resolution data emerged from cryo-
electron microscopy in 1993 4 the scientic community had to
wait until 2000 for the rst crystal structure to appear, the
structure of bovine rhodopsin.5 Since then we have witnessed
the publication of new structures at an ever-accelerating pace
culminating in the Nobel prize in chemistry awarded to Brian
Kobilka6 and Bob Leowitz7 in 2012. The major breakthroughs
in this area of structural biology have recently been reviewed by
Grisshammer.8
Early studies of folding of GPCRs and GPCR-like proteins
comprise the seminal work of the Khorana group that demon-
strated that bacteriorhodopsin (bR) can be refolded from its
fully denatured state.9 While refolding of most GPCRs from the
denatured state is diﬃcult but not impossible, no structure of
a refolded GPCR has been published so far. Most of the folding
studies of GPCRs rather focused on unfolding them in chaot-
ropic agents10 using a number of biophysical or computational11
techniques to characterize the folding intermediates and to
detect folding cores. However, most of the experimental tech-
niques cannot deliver dynamical information at atomic reso-
lution with the notable exception of single-molecule techniques
such as atomic force microscopy (AFM). Those can be used to
map overall conformal preferences of membrane proteins, even
if they do not adopt a unique topology.12–14
The potential of investigating dynamical features of GPCRs
by NMR has been recognized early on, but studies of GPCRs by
NMR are largely hampered by technical issues.15 The seminal
paper by the Nietlispach group reporting on sensory
rhodopsin16 and the structure of proteorhodopsin17 have indi-
cated that solution NMR in principle is capable of determining
the structures of 7-TM membrane proteins. In addition, GPCRs
labeled with only certain amino acid types18–22 or receptors
covalently linked to uorine moieties23,24 have been used to
investigate aspects of receptor activation.
In this review we summarize our work on the use of trun-
cated GPCRs, here referred to as “fragments”, to study inter-
helical contact formation in neighboring TM helices, and ligand
recognition by extracellular loops and the N-terminal domain.
The diﬀerent approaches we followed for using fragments are
depicted in Fig. 1.
We focus on examples from two GPCR families: the human Y
receptors and the yeast mating pheromone receptor Ste2p. The
Y receptor family consists of four members (Y1, Y2, Y4 and Y5),
which all are class A receptors that bind to peptides of the NPY
family. The Y receptors mediate vasoconstriction, stimulation
of food intake, intestinal functions, regulation of circadian
rhythms, and the release of pituitary sex hormones.25 We began
by studying the bindingmechanisms of the NPY ligands to the Y
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receptors. We discovered that binding is orchestrated via a two-
step mechanism, which includes rst association to the cellular
membrane and a second recognition by the extracellular N-
terminal domain and by the extracellular loops of the GPCRs26
following the membrane compartment model initially postu-
lated by Schwyzer.27,28 For these reasons, the peptides of the NPY
family represent an excellent class of ligands whose binding to
membranes or membrane mimetics can be studied in great
detail by NMR. We further used the Y4 receptor to study inter-
helical contact formation in neighboring TM helices. The S.
cerevisiae Ste2p receptor binds the tridecapeptide a-factor
mating pheromone, resulting in growth arrest and gene regu-
lation in preparation for mating.29 Studies on this receptor were
carried out in collaboration with the groups of Naider and
Becker, and largely concern the question of how uncompen-
sated polar residues at central helix position inuence protein
topology.
The membrane compartment model indicates that the
extracellular N-terminal domains or the extracellular loops of
the Y receptors may interact with their ligands. For this reason,
we produced the peptides corresponding to the N terminal
domains of the Y-receptors and studied by NMR their interac-
tion with their ligands (Fig. 1A). We then created amodel for the
extracellular loops of the Y1 receptor by graing the latter in
a topologically related fashion onto a well-behaved membrane
protein scaﬀold derived from the bacterial outer membrane
protein OmpA (Fig. 1A).30,31 This allowed us to study recognition
of the peptide ligands by the loops.32,33 Subsequently, we made
2–3 TM fragments to study the importance of inter-helical
contacts (Fig. 1B), and complemented this approach by
studying folding of a series of overlapping N-terminal fragments
of increasing length (Fig. 1C) by NMR. We further com-
plemented the NMR data with studies on the orientation of
these fragments in the inner membrane of E. coli. Finally, we
briey mention the use of complementary fragments to make
a mimic of a segmentally labeled entire GPCR.
General remarks on studying protein fragments
Does it make much sense to look at protein fragments? This
question is highly disputed. The seminal work from the Kay
group on the study of the entire proteasome by solution NMR
using a divide-and-conquer approach34 showed that such an
approach can elegantly solve many spectroscopic issues of
a system of such size. However, in general the answer for
soluble proteins is “no” because dissecting a protein within
domain borders will usually result in unstructured and insol-
uble aggregates. For certain membrane proteins, however, this
approach might still work. Here, secondary structure formation
is promoted by the hydrophobic environment, because
hydrogen bonds are formed to shield the polar peptide bond
from making unfavorable contacts to lipids.35,36 The successful
design of split receptors of rhodopsin37 and the a-factor
receptor Ste2p38 indicated that receptor fragments can
complement each other, restoring the functionality of the full-
length receptor. The rst structure determination of a GPCR
fragment by NMR39 was encouraged by the nding that cyto-
plasmic fragments of rhodopsin inhibit the interaction between
rhodopsin and its G-protein transducin.40 However, the exact
structural architecture is oen not maintained in GPCR frag-
ments, and hence we feel that the study of fragment structures
is not feasible in order to obtain an atomistic picture of the
entire receptor. Instead, we used GPCR fragments to address
questions of ligand recognition and folding that would be
diﬃcult to address using full-length receptors.
The two-stage membrane-protein folding model proposed by
Popot and Engelman postulates that segments of membrane
proteins form helical structures upon partitioning into the
water–membrane interface.41 These helices subsequently insert
into the hydrophobic core of the membrane and diﬀuse within
the bilayer until contacts with other helices are made eventually
leading to the assembly of the helical bundle. If secondary
structure in membrane environments is predominantly deter-
mined by sequence, and does not depend on the formation of
tertiary contacts, it should be retained in fragments. As
described below in more detail, we usually observe good
agreement between the location of helical segments and
structural models of our GPCRs, an indication that formation of
secondary structure of membrane proteins is indeed primarily
encoded in the immediately neighboring amino acid sequence.
Fig. 1 Potential approaches to study GPCRs from fragments. (A)
Recognition of extracellular (EC) domains. The EC N-terminal domain
is studied in isolation. Alternatively, the EC loops are grafted onto a b-
barrel protein (OmpA) to study binding by NPY peptide ligands. (B)
Formation of interhelical contacts studied in receptors that have been
dissected into 2-TM fragments. (C) NMR is used to study fragments of
increasing length to infer interhelical contact formation and stability of
the TM helices during biogenesis in a lipid environment.
9860 | RSC Adv., 2018, 8, 9858–9870 This journal is © The Royal Society of Chemistry 2018
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Is tertiary structure correctly retained in fragments? A
number of features were proposed to be important for the
formation of inter-helical contacts.42–45 Those are for example
shape-complementary amino acids, e.g. the knobs-in-hole
arrangement in GXXXG motifs.46,47 Another way to mediate
helical contacts is through formation of aromatic sidechain
interactions48 or via formation of hydrogen bonds.49 The latter
requires the presence of polar residues in sequence locations
where they would not be expected based on a match of hydro-
phobicity with the surrounding lipid environment. It is obvious
that exposure of polar residues to lipids will hamper proper
integration of the corresponding stretch into the membrane,
and will additionally destabilize secondary structure.50 The
location of polar residues situated within the membrane is
important since it provides specicity for interhelical contacts,
which should be taken into account by selecting the fragment
such that most of the polar residues nd their interaction
partners within the same fragment if possible. On the other
hand, looking at fragments also oﬀers the possibility to study
the behavior of an N-terminal segment of the protein in the
absence of the remainder of the protein, ideally mimicking
what happens during early biogenesis events within the lipid
bilayer.
Synthetic aspects
Biosynthesis of GPCR fragments
E. coli has been the host of choice for obtaining proteins for
NMR studies because of the possibility to introduce isotope
labels in almost all avors.
Experience from our and other laboratories indicates that it
is possible to generate milligram quantities of puried GPCR
fragments from 1–2 L of E. coli culture, even when growing
cultures with minimal media in deuterated water.50–57 We have
observed that some GPCR fragments are well produced in E.
coli, while others require the use of an N-terminal fusion
partner to increase expression. Among the N-terminal fusion
proteins that we have employed to increase expression are the
DTrp-leader sequence58 or Mistic.59
During protein biogenesis in E. coli, GPCR fragments are
intrinsically prone to aggregation due to their hydrophobic
nature and lack of a recognition sequence for the Sec trans-
locon. Thus, they accumulate in the form of inclusion bodies.
However, inclusion bodies can be solubilized with the aid of
organic solvents such as triuoroacetic acid (TFA),60 or deter-
gents such as SDS or fos-choline-12,51 among other strategies
followed in our group to solubilize insoluble proteins.61,62
Once GPCR fragments are solubilized from inclusion bodies,
we performed a chromatographic separation in presence of
denaturants, such as reverse-phase column or ion metal aﬃnity
chromatography (IMAC), followed by dialysis against water to
remove the denaturant, and lyophilization. Purity and the
correct mass of the protein obtained is veried by mass-
spectrometry. This procedure oﬀers the unique advantage that
the lyophilized material can be solubilized in the required
volume of buﬀer containing detergent, a prerequisite to obtain
reproducible NMR measurements. Furthermore, solubilization
of lyophilized material into small volumes of buﬀers minimizes
the use of expensive deuterated detergents.
We have experienced that some GPCRs fragments could not
be eﬃciently re-solubilized aer lyophilization. This prompted
us to investigate the expression into the inner membrane of E.
coli. GPCRs lack N-terminal signal sequences for insertion into
the membrane, but expression of functional GPCRs in E. coli
sometimes can be achieved by using N-terminal fusion partners
such as the maltose binding protein (MBP),63 or Mistic.59 The
use of N-terminal fusions proved to be useful for GPCR frag-
ments, and allowed us to investigate how the transmembrane
helices of the fragments are oriented in respect to the lipid
bilayer of the E. coli inner membrane (vide infra).
Recognition of GPCRs by their ligands
Our group studied members of the NPY family, ligands for the
Y-receptor GPCRs, using high-resolution NMR both in solution
and in the membrane-bound state.64–67 Based on these studies
we proposed a model for the binding of these hormones to their
cognate receptors,26 which suggests that initial binding of the
ligands to the membrane constitutes an integral part of the
receptor recognition process.27,68
For larger ligands, and in particular in case of peptide
ligands, photoaﬃnity-labeling studies revealed that contact
points between receptors and their ligands can be assigned to
the extracellular face of GPCRs, which is comprised of an N-
terminal domain and three extracellular loops (ECLs) of vari-
able size.69–71 To investigate this aspect we have studied the
interactions of peptides of the NPY family with isolated N-
terminal domains72 or with a chimeric receptor in which all
extracellular loops as well as the N-terminal domain were
graed onto a b-barrel scaﬀold, the membrane protein
OmpA.32,33
The role of the N-terminal extracellular part
We initially investigated conformational preferences of the
extracellular N-terminal domains of all Y receptors.72 While they
are largely unfolded, in case of the Y4 receptor an amphiphilic
helix is formed, which is anchored on the micelle surface,
connected via a long and exible loop to TM1 (Fig. 2). Inter-
estingly, the ligand pancreatic polypeptide (PP), another
member of the NPY family of neurohormones, binds with a 50
mM aﬃnity to that loop as determined by surface-plasmon
resonance, largely via electrostatic interactions.73 In a rst
step, ligands associate with the membrane surface, and diﬀuse
laterally.26 In proximity to the receptor a weak interaction of PP
with the N-terminal domain helps transferring the peptide from
the membrane-bound state to the receptor binding-pocket
following a y-casting mechanism (Fig. 2).
The role of extracellular loops
Binding aﬃnities to isolated receptor loops are oen in the mM
range74 while binding aﬃnities to full-length receptors
commonly are in the nM range (see http://gpcrdb.org/
interaction/ for an overview of ligand binding data). The
This journal is © The Royal Society of Chemistry 2018 RSC Adv., 2018, 8, 9858–9870 | 9861
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cumulative eﬀects of two or more mM binding sites present in
two separate loops can explain the higher binding-aﬃnities for
the entire receptor, amongst other factors.
Since formation of proper tertiary structure per se is ques-
tionable in fragments, it is highly unlikely that the loop
conformations in isolated TM fragments will be meaningful.
Graing the loops onto a suitable scaﬀold could allow for the
simultaneous display of several (ideally all) binding epitopes of
a GPCR in approximately correct relative orientations and could
hence serve as a suitable GPRC-mimic for biophysical or
structural studies. We therefore selected a scaﬀold that can
accommodate at least three extracellular loops of the Y1
receptor, can easily be biosynthesized and handled, resides in
the membrane, and also can be characterized by solution NMR.
In the resulting chimeric receptor, we graed the loops of the
Y1 receptor onto the b-barrel scaﬀold derived from the E. coli
outer membrane protein A (OmpA) by replacing three of its four
loops at one side of the barrel by the Y1 receptor extracellular
loop sequences (Fig. 3).32,33 The three loops can be transferred in
various arrangements onto the scaﬀold. We ranked the diﬀerent
topomers according to how similar distances of loop-anchoring
residues are with respect to known GPCR structures and chose
to biosynthesize four candidates that most closely resemble the
native receptors. All of those constructs expressed well and
could be refolded. Using chemical shi mapping and
saturation-transfer NMR techniques we demonstrated that the
chimeric receptor recognizes the native ligand NPY in a specic
manner.32 We have also transferred the extracellular domain
onto the remaining accessible b-barrel scaﬀold loop acceptor
position, but could not detect an increase in binding aﬃnity.33
The aﬃnity between these chimeric Y1 receptors and NPY are in
the micromolar range, which is 2–3 orders of magnitude weaker
than the interaction between NPY and the native Y1 receptor.
This discrepancy can be attributed to diﬀerences in the topology
of the chosen template, in particular in diﬀerent relative loca-
tions of the loop anchoring points. Alternatively, X-ray struc-
tures of GPCRs with peptide ligands,75 unknown at the outset of
our study, later revealed that additional interactions formed
between the ligand and TM residues are involved in ligand
binding.
Graing loops of GPCRs onto soluble scaﬀolds has been
successfully demonstrated in case of the RXFP1 receptor76,77
using the B1 immunoglobulin binding domain of the strepto-
coccal protein G (GB1) as the scaﬀold. Similarly, the N terminal
domain and the third extracellular loop of the PTH receptor
were graed onto the four-helix bundle protein TM1526 from
the thermophilic archaea bacteria Thermotoga maritime.78 Last
but not least it was also demonstrated that a polypeptide, in
which the extracellular loop sequences of the CXCR4 receptor
were connected via appropriate spacers recognizes gp120 with
good aﬃnity.79,80
Folding of GPCRs
A study of overlapping TM fragments from the Ste2p receptor
Cotranslational insertion of membrane proteins into the lipid
bilayer is a vectorial process that starts from the N-terminus of
the nascent chain. When studying folding of GPCRs, the use of
N-terminal fragments presents a conceptual advantage over
investigating the entire receptors, because C-terminal segments
Fig. 2 Model for binding of PP to the Y4 receptor comprising association with themembrane surface (left), formation of transient contacts to the
N-terminal domain (left) and diﬀusion into the orthosteric binding pocket (right).
Fig. 3 Binding of the ligand peptide NPY to the chimeric model of the Y1 receptor. (A) Ligand binding studies by saturation transfer diﬀerence
(STD). The reference spectrum is depicted at the bottom. The strong STD signal at 6.9 ppm stems from the aromatic protons of Y27. (B)
Chemical shift perturbations in NPY upon binding to the chimeric receptor. Residues for which amide resonances are shifted to the largest extent
are encircled in the helical wheel presentation and are colored in red in the ribbon representation of NPY.
9862 | RSC Adv., 2018, 8, 9858–9870 This journal is © The Royal Society of Chemistry 2018
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of the receptor are not present when the rst N-terminal
segments have been made and are ready for insertion into the
membrane. Since we suspected that the TMs mutually stabilize
each other, we set out to investigate a series of N-terminal
fragments derived from the yeast GPCR Ste2p of increasing
size that always start with TM1 (Fig. 4).81
Initially, we determined the structure of TM1 in LPPG/DPC
mixed micelles. Instead of one continuous helix our NMR
analysis revealed that this fragment is composed of two sepa-
rate, rather well-dened short helices comprising residues
Thr48–Phe55 and Ala61–Ile71 (Fig. 4C). These two helical segments
are spaced by the amino acid sequence GSRVG. The orientation
of the two short helices relative to each other was poorly
dened.
When adding residues from the second TM, we detected
interhelical contacts between TM1 and TM2 via NOEs between
methyl groups, and TM1 now formed a continuous helix. This
observation indicates that the presence of TM2 stabilizes
secondary structure (around the GXXXG motif) in TM1 when
compared to the isolated TM1, resulting in a helical hairpin for
TM12 (Fig. 4C and D).
Unfortunately, the fragment TM123 is rather unstable and
tends to aggregate. However, backbone assignments of TM123
were still possible, and both deuterium amide exchange and
attenuation from soluble spinlabels indicated that there is
water-access to the central part of TM3. This indicates that TM3
does not stably pack against TM1 and/or TM2. In contrast, the
construct TM127, in which TM7 is articially covalently linked
to the loop of TM2, proved to be much more stable. Assuming
that TM7 packs against TM1 and TM2 in the entire receptor,82
this fragment allowed us to investigate the formation of inter-
helical contacts. Spectroscopic properties of TM1 and TM2 in
TM127 changed only minimally, indicating that the helical
hairpin is not signicantly altered upon addition of TM7.
However, TM7 similarly as TM3 does not stably pack against
TM1 or TM2, but displays motions around an internal exible
hinge comprised by the central Leu-Pro-Leu tripeptide motif. In
contrast to TM3, however, TM7 appears to be better integrated
into the hydrophobic core, as we did not observe access of water
to TM7.
Two principles emerged from that study that are particularly
worth mentioning: (i) the stability of secondary and tertiary
Fig. 4 Study of C-terminally truncated forms of the Ste2p receptor. (A) Schematic representation of the Ste2p receptor (left) and inter-helical
contacts (right). (B) Schematic representations of TM1, TM12 and TM123/TM127. (C) Experimental (NMR) structures of TM1, when individually
superimposing individual conformers of the N- and C-terminal halves of TM1 separately (left), or when superimposing all residues (right). Other
structures present conformers of TM12 or TM127 (two diﬀerent conformers depicted). (D) Schematic representations of the experimental
structures.
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structure depends to a large extent on the presence of polar or
charged residues in regions that are placed within the
membrane interior. (ii) Fragments in general do not stably
insert into the membrane.
We like to briey mention that we started our work on
fragments of the Ste2p receptor with TM7, using a construct
that also comprises 40 residues from the C-terminal intracel-
lular domain.83 The protein was expressed and puried in the
lab of Fred Naider, and we determined the structure in DPC
micelles. Similarly to TM1, the NMR data revealed that TM7 is
not stably folded but rather exists in form of two helical
stretches interrupted around a central Pro residue. The two
helix portions are not stably anchored in the hydrophobic core
of the micelles but transiently buried.
All NMR studies described above are performed using
detergent micelles as membranemimetics, and these have been
used also for many crystallographic studies of membrane
proteins. Detergent micelles, however, do not perfectly reect
planar bilayers as encountered in biological membranes nor do
they contain non-lipid components such as other membrane
proteins (integral or peripheral) or glycolipids. To obtain data
on partitioning into real biological membranes we have
collaborated with the group of Ismael Mingarro from Alicante
University. His group performed assays on liver microsomes,
relying on the absence or presence of glycosylation to probe for
the periplasmic location of the C-terminus of the fragments.81
The conclusion from that work was that TM1 is not integrated
into the membrane but TM12 and TM123 or TM127 mostly
assumed native-like topology. A peptide corresponding to the
more hydrophobic TM2 did insert into the membrane, and
replacing Arg-58 at the center of TM1 by Leu or Ala also resulted
in insertion. These studies indicate a pivotal role of uncom-
pensated polar or charged residues within central locations of
TM helices for folding and membrane-integration.
The importance of interhelical contacts
NMR studies of double-TM fragments from the Y4 receptor.
We have also investigated formation of secondary structure and
interhelical contacts in a series of 2-TM fragments derived from
the human Y4 receptor. We studied TM12,50,84 TM45, TM56 and
TM67 51 to obtain a series of overlapping polypeptides that
would span the entire Y4 receptor. We managed to obtain close-
to-complete backbone chemical shi assignments for most
residues, both from loops as well as from the TM helices, with
the notable exception of most residues from TM3 and TM4.
Secondary chemical shis of assigned TM residues indicate that
the secondary structure in the putative TM portions is correct in
the 2-TM fragments. We suspect that resonances from residues
TM3 and TM4 were broadened through conformational
exchange, reecting the fact that TM helices oen do not pack
stably against each other in fragments. However, conforma-
tional broadening is also observed on entire receptors and the
intrinsic instability is of importance for the mode of receptor
activation.
Interestingly, in contrast to the corresponding fragment
from the Ste2p receptor the structure of TM12 of the Y4 receptor
did not show tertiary contacts.50 Secondary structure is largely
formed, however, and interrupts occur close to Gly, Pro or polar
residues. A comparison of these two structures is depicted in
Fig. 5. Please note the much more frequent occurrence of polar
residues in TM1 or TM2 of the Y4 receptor when compared to
the Ste2p receptor.
In principle, one could try to construct an entire receptor
from two complementary fragments. If such a fragment
complex would be capable of still binding the ligand, the
method would facilitate the NMR resonance assignment
tremendously. Seminal work by the Khorana lab, which recon-
stituted active bacteriorhodopsin from complementary frag-
ments, indicated that this should indeed be feasible.85 Similarly
Dumont could reconstitute the Ste2p receptor from several
pairs of complementary fragments.38 Note that in the work by
the Dumont group the two fragments were co-expressed, and
the Khorana group used cleavage of reconstituted bacteriorho-
dopsin to generate the fragments. We have tried to mix sepa-
rately expressed fragments of the Ste2p receptor, e.g. TM12 86
with TM34567,87 but so far failed to develop protocols to form
protein complexes from fragments individually dissolved in
detergents.
Folding of GPCRs in vivo
Topogenesis studies of Y4 receptor fragments. Although the
topology of G-protein coupled receptors is well known from
crystal structures, it is diﬃcult to correctly predict how GPCR
fragments will be oriented in the lipid bilayer. An extensive
analysis of the topology of all possible N- or C-terminally trun-
cated receptor fragments by NMR is impossible. Topology
analysis performed into the E. coli inner membrane, with the
aid of reporters for cytoplasmic or periplasmic localization of
the TM termini, provides low-resolution structural information
on the orientation of transmembrane helices relative to the
lipid bilayer.88
To compare the data obtained in vitro by NMR with the
topology of fragments in a cellular membrane environment,
and to possibly determine whether the lack of interhelical
contacts that we observed for TM12 of the Y4 receptor was
inuenced by the detergent used for NMR (Fig. 5), we have
performed a topology analysis by truncating the entire receptor
by one helix at a time, starting from both the N-terminus and
the C-terminus.89We used GFP as a reporter for cytoplasmic and
alkaline phosphatase (PhoA) as a reporter for periplasmic
localization.88 A schematic of the approach is presented in
Fig. 6A and B.
Since the N-terminus is likely either in the periplasmic or in
the cytoplasmic compartments for the N-terminally truncated
constructs, depending on how many helices were removed, we
have used two diﬀerent N-terminal fusion proteins to perform
the study: the transmembrane region of the bacterial peptidase
Lep was used to ensure proper periplasmic orientation,90 while
Mistic was used to ensure cytoplasmic orientation (Fig. 6B
and D).
The information acquired by combining the results from the
GFP and PhoA reporters allowed quantifying the fraction of
9864 | RSC Adv., 2018, 8, 9858–9870 This journal is © The Royal Society of Chemistry 2018
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expressed protein that folds in a topology that resembles the
organization in the entire receptor. Interestingly, we could
observe that N-terminal fragments do not acquire a unique
topology, however, the fraction displaying the correct localiza-
tion of the C-terminus increased with the number of helices
that were added. A scheme displaying the possible topologies
for the two short fragments TM1 and TM12 of the Y4 receptor,
and experimental data on the location of the C-terminus are
depicted in Fig. 6B and D.
In case of TM1, two topologies are possible for each fusion
(Fig. 6B): a dual topology is observed in case of fusion with Lep
(Fig. 6B and C), while a predominant cytosolic location exists for
Mistic-TM1 (Fig. 6D and E). Conversely, for TM12 when fused to
Lep, it predominantly adopts a periplasmic location (Fig. 6B
and C), while when fused to Mistic it adopts dual topology
(Fig. 6D). Possible orientation of the TM helices with respect to
the E. coli inner membrane, considering the positive inside
rule91 are reported (Fig. 6B and D). Our topology data are in good
agreement with predictions of insertion based on the free
energies of transferring entire TM helices into the membrane
(Fig. 6F).92,93 They reveal that the rst three helices, and in
particular TM1, are unlikely to insert, while the sequences of
TM4–6 strongly favor insertion.
Discussion
During membrane protein folding, interactions both with water
as well as with lipids are relevant. Membrane protein biosyn-
thesis is a vectorial process, and hence not all native (polar)
tertiary contacts may be possible when the rst TM helices are
ready for insertion into the membrane. Therefore, non-native
interactions with water or lipids may be formed that could
possibly inuence the folding pathway.
In eukaryotes membrane protein biosynthesis occurs at the
ribosome in the ER starting at the N terminus from which the
nascent chain is transferred via the signal recognition particle
(SRP), which targets the nascent chain to the ER inner
membrane.94,95 From the SRP the chain is transferred to the
large channel of the translocon machinery (Fig. 7A). In the
original co-translational folding model, the emerging poly-
peptide chain is translocated or partitioned into the hydro-
phobic environment of the membrane bilayer, where the
translocon decides which parts of the chain to translocate and
which to insert.96–98 The insertion of helices into hydrophobic
environments depends on biophysical properties of the amino
acid sequence in the corresponding stretch. Wimley and White
experimentally determined the free energy of transferring
amino acids into the membrane interior or the membrane
interface.92,93 Similarly, von Heijne has established an in vivo
translocon-based scale, that qualitatively largely agrees with the
in vitro data.99,100 Both scales qualitatively describe the
membrane integration behavior and conformational prefer-
ences surprisingly well.
Engelman and Popot in their two-stage model for folding of
helical membrane proteins41,101 postulated that helices sponta-
neously form once the segments coding for the TM helices
insert into the membrane. This is the case because formation of
secondary structure prevents that polar moieties of the peptide
bond form unfavorable contacts with lipids. Following the
coupled insertion/folding step helices diﬀuse in the membrane
until the proper interhelical contacts are formed. In this
simplest form the model requires that helices remain inserted
Fig. 5 Location of polar residues in TM helices in the Y4 (left) and Ste2p (right) receptors. Models of the Y4 (A) and Ste2p (B) receptors. Atoms of
side-chains of polar residues in TM helices at least 6 residues away from the helix ends are depicted as spheres. TM1 and TM2 are colored in red,
TM3–TM7 in light blue. (C) Single NMR conformers of TM12 from the Y4, and (D) the Ste2p receptors along with the surface potential of TM12 of
Ste2p. Positively and negatively charged surfaces are color coded in red and blue, respectively.
This journal is © The Royal Society of Chemistry 2018 RSC Adv., 2018, 8, 9858–9870 | 9865
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until the entire chain has been biosynthesized, all inter-helical
contacts are formed, and folding is completed. Recent evidence,
however, indicates that individual helices of integral membrane
proteins are oen marginally stable in the hydrophobic inte-
rior,102 and many helices are not even expected to insert at all.
The reason for this at rst sight surprising property is the fact
that TM helices oen contain polar or even charged residues –
these mediate the specic inter-helical contacts that drive the
assembly of the helical bundle.103–106 It is a legitimate question
to ask what happens with these marginally stable TM helices
when other helices that provide the compensating interactions
are not present because they have not been synthesized yet. Will
they remain in the hydrophobic interior, or will they become
surface associated? If they partition into the interface, will they
fully re-insert once the missing TMs have been synthesized? Or
do they need to be stored close to the translocon until all parts
of the chain have become available?
We propose that these questions can be best addressed when
studying protein fragments. These oﬀer the conceptual
advantage, when compared to the study of the entire proteins
under slightly denaturing conditions, that parts, which are
biosynthesized later, are not contained in the construct and
hence cannot form any interactions. Solution NMR studies of
fragments in membrane-mimicking environments allow
studying structural details of early folding intermediates. In this
review we have outlined our eﬀorts to study folding and recog-
nition of GPCRs from fragments.
To summarize, we have learnt that secondary structure in
these fragments largely corresponds to the prediction from
homology models. Hence, secondary structure is likely encoded
in the local sequence, and does not completely depend on the
formation of tertiary contacts as in the case of soluble proteins.
In contrast, tertiary contacts are mostly not formed, and the
occurrence and persistence of these contacts is related to the
location and number of polar or charged residues located
within the hydrophobic compartment of the membrane. The
work on TM1, TM12 and TM123 or TM127 of Ste2p indicates
that longer fragments integrate better into the membrane and
Fig. 6 Topology analysis of Y4 GPCR fragments of increasing length into the inner membrane of E. coli. (A) Schematic representation of the
assay used to study the topology of membrane insertion. When the C-terminus of a membrane protein is located in the periplasm, fusion to
alkaline phosphatase (PhoA) allows detection of enzymatic activity. In case of cytoplasmic location of the C-terminus, GFP ﬂuorescence can be
measured. (B) Schematic representation of the Lep-fusion to TM1 and TM12 of the Y4 receptor and their possible topologies in the E. coli inner
membrane, considering the distribution of positive and negative charges in the loops and the occurrence of polar or charged residues within the
TM helices. (C) Experimental results of the topology assay of the Lep-fusions constructs, reporting the Y4 fragments of increasing length starting
from the N-terminus of the Y4 receptor. (D) Schematic representation of the Mistic-fusion to TM1 and TM12 of the Y4 receptor, and possible
topologies considering the distribution of positive and negative charges in the loops. (E) Experimental results of the topology assay for fragments
of the Y4 receptor fused to Mistic. (F) Free energies for partitioning the entire TM peptide into the membrane using the scale from Wimley and
White.92,93
9866 | RSC Adv., 2018, 8, 9858–9870 This journal is © The Royal Society of Chemistry 2018
RSC Advances Review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
9 
M
ar
ch
 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
6/
03
/2
01
8 
20
:1
1:
00
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
more likely form tertiary structure. Similarly, the systematic
topogenesis study of the series of Y4 receptor fragments clearly
indicates that fragments containing more TM helices insert
more stably and in a more dened topology. Importantly, TM1
of the Y4 receptor is predicted to not partition into the
membrane,107 and when taking this feature into account the
topology of the truncated fragments can be predicted rather
reliably (see Fig. 7).
Inside the translocon, hydrophobic segments are laterally
gated through a cle into the membrane interior.108 Which
segments are partitioned into the membrane interior is believed
to be primarily decided based on hydrophobicity, a property
that is reected in the biophysical properties of the amino acid
sequence.109 If TM helices are suﬃciently hydrophobic they will
remain inserted in the membrane and diﬀuse until the native
contacts are made and the protein has assumed its nal
topology (Fig. 7A). However, when TM helices contain charged
or many polar residues they may not properly insert and rather
become surface associated. Once all remaining TM helices are
released by the translocon, these surface-associated helices may
form the compensating interactions and re-insert (topological
maturation94) (Fig. 7B). Alternatively, TM segments may remain
within or near to the translocon (Fig. 7C) to be released into the
hydrophobic interior only once the entire polypeptide chain has
been made (Fig. 7C).94
Interesting experimental results concerning cellular mecha-
nisms of a-helical membrane protein biogenesis were obtained
on the two closely related water-channel proteins aquaporin-1
(AQP1) and aquaporin-4 (AQP4). Using truncated fragments it
was demonstrated that TM segments of AQP4 leave the trans-
locon one aer another in a perfectly sequential mode, and
insert into the membrane in the correct topology (correspond-
ing to Fig. 7A).110,111 In contrast, TM2 of AQP1 does not termi-
nate translocation and therefore is partitioned into the ER
lumen instead of into the membrane resulting in a four-TM
instead of the native 6-TM bundle.112 The group of Dowhan
has demonstrated how changes in the composition of the
phospholipids switch the topology of helical membrane
proteins in a non-assistedmanner,113,114 and hence spontaneous
topology maturation may occur (Fig. 7B). On the other hand,
Fig. 7 Models for co-translational folding. (A) TM helix segments are immediately released into the hydrophobic core, remain there and diﬀuse in
the membrane until proper inter-helical contacts are made. (B) Immediate release of TM segments into the hydrophobic core. Depending on
hydrophobicity some will locate in the interface. Once all TMs are made and helices transiently located in the interface, they will fully insert when
proper contacts are made. (C) TM helices remain associated within the translocon until all helices are made, and then the bundle is transferred
into the hydrophobic core. In (1) the TMs accumulate inside the translocon, while in (2) they are stored outside the translocon such that the
hydrophilic sides (shown in blue) point into the interior of the channel. Figure modiﬁed from Skach.94
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photo-crosslinking experiments indicated that TM helices
might form either specic or nonspecic contacts with residues
from the translocon,115 and that TM helix bundles could leave
the translocon and enter the lipid bilayer in a concerted
manner.110,116–118 Using chemical cross-linking it was also shown
that large portions of opsin remain bound or associated to the
translocon during ribosomal synthesis.119 Recent data on the
structure of a ribosome-nascent chain translocon complex
revealed that TM1 and TM2 of proteorhodopsin inserted into
the membrane close to the lateral gate.120 Based on this obser-
vation von Heijne and White have suggested that TM helices
never fully insert into the translocon but rather slide along the
lateral gate.121 Possibly, polar side chains may then still point
into the translocon channel in order to escape forming contacts
to lipids, while most of the hydrophobic part would be placed
rather outside the translocon (Fig. 7C (path 2)). We noticed that
such a scenario would help to reduce space requirements for all
TMs in the translocon interior. Our data will not allow deciding
on the exact details of Ste2p or Y4 GPCR biogenesis, but they
provide molecular details of early states during the folding in
a valid environment and help understanding the underlying
biophysics.
In principle, recognition of peptide ligands by their GPCRs
again concerns the interaction of polypeptide chains in a lipid
environment, this time of course for separate chains. Our
studies revealed interactions of the pancreatic polypeptide PP
with the N-terminal extracellular domain. These suggest that
the ligand is transferred via a y-casting mechanism from the
membrane-associated state into the ligand-binding pocket,
which is mostly formed by the extracellular loops. In fragments
the orthosteric ligand-binding site is either not present or not
fully formed, and hence this weak interaction, while likely
short-lived in the entire receptor, can still be observed. The
graing work demonstrates that extracellular loops provide
binding aﬃnity for the ligands when provided in an approxi-
mately correct topology. However, the work also showed that the
binding aﬃnity for the graed model is signicantly lower than
for the entire receptor. This work therefore highlights
a constant dilemma when working with fragments – they
provide much conceptual insight into folding or binding but
can never fully reproduce the natural system. Nevertheless, we
believe that the information gained on these systems justies
using fragments to address specic questions of folding and
binding.
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